Purchase Short-Term Access

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease: A Randomized, Controlled Trial
David B. Badesch, MD; Victor F. Tapson, MD; Michael D. McGoon, MD; Bruce H. Brundage, MD; Lewis J. Rubin, MD; Fredrick M. Wigley, MD; Stuart Rich, MD; Robyn J. Barst, MD; Pamela S. Barrett, PharmD; Kenneth M. Kral, MS; Maria M. JoĢˆbsis, BA; James E. Loyd, MD; Srinivas Murali, MD; Adaani Frost, MD; Reda Girgis, MB, BCh; Robert C. Bourge, MD; David D. Ralph, MD; C. Gregory Elliott, MD; Nicholas S. Hill, MD; David Langleben, MD; Robert J. Schilz, DO, PhD; Vallerie V. McLaughlin, MD; Ivan M. Robbins, MD; Bertron M. Groves, MD; Shelley Shapiro, MD, PhD; Thomas A. Medsger, MD; Sean P. Gaine, MB, BCh; Evelyn Horn, MD; James C. Decker, MS; Katharine Knobil, MD
Annals of Internal Medicine 2000;132:425-434. doi:10.7326/0003-4819-132-6-200003210-00002

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.